Pharmaceutical company Double Bond Pharmaceutical has terminated the agreement with Mangold regarding a liquidity guarantee for the company's share on Spotlight Stock Market. The company considers trading activity and liquidity in the share to be satisfactory and is therefore terminating the service. The agreement was entered into in 2025 and the liquidity guarantee ended after the close of trading on 24 August this year.